RenovoRx, Inc. (RNXT) stock
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.95−0.09 (-8.18%)
Close on Nov 16, 2026Market cap $43.09MP/E –Yield –
RenovoRx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
RenovoRx's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.87M. For fiscal 2025 it was -$10.97M. The highest annual figure on record is -$3.53M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.97M | – |
| FY2024 | Dec 31, 2024 | -$9.13M | – |
| FY2023 | Dec 31, 2023 | -$10.26M | – |
| FY2022 | Dec 31, 2022 | -$8.81M | – |
| FY2021 | Dec 31, 2021 | -$5.92M | – |
| FY2020 | Dec 31, 2020 | -$3.53M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.87M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.71M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.02M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.27M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.30M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.38M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.43M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.19M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.30M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.20M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.05M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.73M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.77M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.68M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.67M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.36M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.56M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.12M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.25M | – |
| Q1 FY2021 | Mar 31, 2021 | -$992.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$970.00K | – |
See a number that looks wrong?